NCT03650673

Brief Summary

The late-stage forms of degenerative osteoarthritis (OA) are very debilitating and less affordable to therapy. The main objective is to identify early onset symptoms of hand OA patients through imaging techniques (such as ultrasound and MRI). Our primary endpoint is to specify patients with high risk of radiological profression (X-ray).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
30mo left

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Jul 2019Oct 2028

First Submitted

Initial submission to the registry

August 22, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 29, 2018

Completed
11 months until next milestone

Study Start

First participant enrolled

July 15, 2019

Completed
9.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2028

Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

9.1 years

First QC Date

August 22, 2018

Last Update Submit

September 24, 2025

Conditions

Keywords

Hand osteoarthritisProspective cohortCartilageMobility

Outcome Measures

Primary Outcomes (1)

  • Radiographic progression judged by the number of joints whose KL index has evolved

    Evaluation of prognostic role of imaging factors in x-ray progression of early onset hand osteoarthritis

    2 years

Secondary Outcomes (19)

  • The number of painful / swollen or deformed joints in the hands.

    2 years

  • The location of painful / swollen or deformed joints in the hands.

    2 years

  • The intensity of pain over the last 48 hours

    2 years

  • The activity of the disease over the last 48 hours

    2 years

  • The aesthetic impact of osteoarthritis of the hands

    2 years

  • +14 more secondary outcomes

Study Arms (1)

Diagnostic Test: Identification of subgroups of patients with

OTHER
Diagnostic Test: Identification of subgroups of patients with early AD with risk of progression

Interventions

Clinical examination with questionnaires, Biological collection, Imaging (radiography, densitometry, ultrasound, and MRI)

Diagnostic Test: Identification of subgroups of patients with

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \- Early digital osteoarthritis must combine the clinical AND radiological definition.
  • Clinical definition:
  • At least one of the following 4 criteria: Pain or stiffness or swelling or deformity of a digital joint (IPP and / or IPD) A breach of at least one PPI and / or IPD Age under 60 at the time of the first symptoms Clinical symptoms have been changing for less than 3 years
  • Radiographic definition:

You may not qualify if:

  • \- Consent form signed
  • patients suffering from rheumatoid arthritis, rheumatoid psoriasis or any other inflammatory rheumatism
  • patients suffering from metabolic diseasis such as gout, hemochromatosis, Wilson's disease; or from congenital disease such as displasie, osteogenesis,
  • Presence of advanced radiographic osteoarthritis based in Kellgreen Lawrence score (=4) in one joint among the 10 previous sites.
  • Not able to provide a sample of blood for any reasons
  • MRI contraindication
  • Subject non affiliated to social insurance
  • Pregnant or lactating women
  • Vulnerable people based in L1121-5 article of CSP
  • Elderly subject or protected subjects disabled to give their consent
  • Subjects private of freedom by court or administrative order

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rheumatology, CHU Montpellier

Montpellier, 34295, France

RECRUITING

Study Officials

  • Yves-Marie PERS, MD

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yves-Marie PERS, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2018

First Posted

August 29, 2018

Study Start

July 15, 2019

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

October 31, 2028

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations